Nanoparticle vaccine approach takes on a new target: Hepatitis C virus
Phys.org
March 4, 2026
Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs can cure most infections, global access remains limited and these drugs do not stop reinfection.
Verticals
sciencephysics
Originally published on Phys.org on 3/4/2026